DTSI up +7.49% percent right now. $DTSI High is at 33.01

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:47 PM

DTSI up +7.49% percent right now. $DTSI High is at 33.01 and the Low 30.05 with current volume of 236,586.

Recent News posted below.

DTSI DTS Inc Recent Headline News

Update: DTS Inc. - Earnings As Expected And A Time To Take Profits
Soid Ahmad - at Seeking Alpha - Tue Nov 11, 2:27AM CST

DTSI: 33.01 (+2.30)

DTS's (DTSI) CEO Jon Kirchner on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 5:19PM CST

DTSI: 33.01 (+2.30)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 4:36PM CST

DTSI: 33.01 (+2.30), W: 24.65 (-3.45), HALO: 8.92 (-0.40), MODN: 10.52 (+0.42), CALL: 8.70 (-1.79), LLNW: 2.67 (+0.17), KRG: 27.04 (+0.10), VSLR: 11.54 (-3.20), CMLS: 3.16 (-0.13), SSE: 11.56 (-0.55)

DTS beats by $0.12, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:54PM CST

DTSI: 33.01 (+2.30)

DTS (DTSI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST

DTSI: 33.01 (+2.30)

DTS beats Street 3Q forecasts
Automated Insights - Mon Nov 10, 3:24PM CST
CALABASAS, Calif. (AP) _ DTS Inc. (DTSI) on Monday reported net income of $3.9 million in its third quarter.
DTSI: 33.01 (+2.30)

DTS Reports Strong Third Quarter 2014 Financial Results
GlobeNewswire - Mon Nov 10, 3:10PM CST
DTS, Inc. (Nasdaq

TSI), a leader in high-definition audio solutions, today announced financial results for the third quarter ended September 30, 2014.
DTSI: 33.01 (+2.30)

45.7% Return Seen to Date on SmarTrend DTS Inc Call (DTSI)
Comtex SmarTrend(R) - Mon Nov 10, 12:27PM CST
SmarTrend identified an Uptrend for DTS Inc (NASDAQ

TSI) on August 12th, 2014 at $20.81. In approximately 3 months, DTS Inc has returned 45.65% as of today's recent price of $30.31.
DTSI: 33.01 (+2.30)

Will DTS, Inc. (DTSI) Surprise Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 4:00PM CST
Entertainment technology provider DTS Inc. (DTSI) is set to release the third-quarter earnings on Nov 10, 2014 following the closing bell.
DLB: 43.30 (+0.27), DTSI: 33.01 (+2.30), SSYS: 101.89 (-3.00), SNE: 20.61 (+0.11)

j2 Global Tops Q3 Earnings, Revenues; Hikes Dividends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:40AM CST
j2 Global Inc. (JCOM) reported record revenues in the third quarter of 2014. Both the top and the bottom line outpaced the Zacks Consensus Estimate.
DTSI: 33.01 (+2.30), JCOM: 56.11 (+0.36), ATTU: 8.99 (+0.09), QLYS: 35.63 (-0.37)

YOU On Demand Holdings, Inc. (YOD) in Focus: Stock Soars 27.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:21AM CST
YOU On Demand Holdings, Inc. (YOD) was a big mover last session, as the company saw its shares surge by over 27% on the day.
DTSI: 33.01 (+2.30), IDCC: 50.08 (+0.38), YOD: 2.65 (-0.02), AAPL: 108.83 (unch)

Paycom Software, Inc. (PAYC) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:18AM CST
Paycom Software, Inc. (PAYC) was a big mover last session, as the company saw its shares surge by over 19% on the day.
DTSI: 33.01 (+2.30), ATTU: 8.99 (+0.09), QLYS: 35.63 (-0.37), PAYC: 22.86 (+0.79)

Iridium Communications Inc. (IRDM) in Focus: Stock Jumps 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 8:21AM CST
Iridium Communications Inc. (IRDM) was a big mover last session, as the company saw its shares rise by over 7% on the day.
DTSI: 33.01 (+2.30), IRDM: 9.97 (+0.02), IDCC: 50.08 (+0.38), AAPL: 108.83 (unch)

OPOWER (OPWR) Crumbles: Stock Falls over 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:32AM CST
OPOWER's shares dropped over 6% yesterday trading at a volatile range of $16.75–$18.36 in the past one-month time frame.
RDWR: 18.89 (-0.27), DTSI: 33.01 (+2.30), ATTU: 8.99 (+0.09), OPWR: 17.49 (+0.17)

Uptrend Call Working As DTS Inc Stock Rises 45.0% (DTSI)
Comtex SmarTrend(R) - Mon Nov 03, 9:35AM CST
SmarTrend identified an Uptrend for DTS Inc (NASDAQ

TSI) on August 12th, 2014 at $20.81. In approximately 3 months, DTS Inc has returned 44.98% as of today's recent price of $30.17.
DTSI: 33.01 (+2.30)

Attunity, Ltd. (ATTU) Jumps: Stock Rises 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:57AM CST
Attunity, Ltd. (ATTU) was a big mover last session, as the company saw its shares rise over 8% on the day.
DTSI: 33.01 (+2.30), RDWR: 18.89 (-0.27), FFIV: 126.12 (-0.47), ATTU: 8.99 (+0.09)

More Top Officers Quit at Twitter: Time to Worry? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 4:06PM CDT
Following the departure of former Chief Operating Officer Ali Rowghani and head of Twitter news efforts, Vivian Schiller, Twitter, Inc. (TWTR) witnessed the departure of some more top brass.
DTSI: 33.01 (+2.30), FB: 74.27 (-0.73), TWTR: 38.96 (-0.63), GOOG: 549.54 (+2.05)

Harman Blowout Quarter Leads Consumer Sector Higher
at Investor's Business Daily - Thu Oct 30, 11:58AM CDT
Harman International Industries (HAR) stock climbed as much as 12% early Thursday, leading a consumer electronics sector surge. Harman reported higher-than-expected fiscal first-quarter earnings, named a new chief financial officer and authorized a...
SKUL: 8.15 (-0.11), DTSI: 33.01 (+2.30), HAR: 106.67 (-1.14), UEIC: 59.10 (+0.25)

DTS Inc Has Returned 35.2% Since SmarTrend Recommendation (DTSI)
Comtex SmarTrend(R) - Mon Oct 27, 9:13AM CDT
SmarTrend identified an Uptrend for DTS Inc (NASDAQ

TSI) on August 12th, 2014 at $20.81. In approximately 3 months, DTS Inc has returned 35.25% as of today's recent price of $28.15.
DTSI: 33.01 (+2.30)

NIC Inc Slumps: EGOV Falls 11.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 7:43AM CDT
NIC stock fell over 11% in the last trading session, falling below its one month volatile price range of $16.62 to $18.96
RALY: 10.56 (+0.01), DTSI: 33.01 (+2.30), MKTO: 33.50 (+0.73), EGOV: 17.12 (+0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...